OLIGONUCLEOTIDES FOR MODULATING CD73 EXON 7 SPLICING Application WO-2021170697-A1 World Intellectual Property Organisation (WIPO) 02 Sep 2021
OLIGONUCLEOTIDE BASED EX VIVO CELL THERAPY Application WO-2021064235-A1 World Intellectual Property Organisation (WIPO) 08 Apr 2021
COMBINATION THERAPY INVOLVING ANTI-CD39 ANTIBODIES AND ANTI-PD-1 OR ANTI-PD-L1 ANTIBODIES Application WO-2020172597-A1 World Intellectual Property Organisation (WIPO) 27 Aug 2020